Pioneering Neurotechnology

Neumo was founded on a bold vision: to use neurotechnology to better understand and enhance driver safety. Co-founder and Chief Scientific Officer Peter Freer developed our core technology to help people reduce distractions and improve focus, leading to Play Attention—now the most widely used neuroscience program for ADHD. Validated by academic research, Play Attention has empowered countless students to thrive.

Today, we’re bringing this transformative technology to the driver’s seat. Neumo’s advancements allow vehicles to monitor drivers’ cognitive states, detecting signs of distraction or drowsiness—all without physical contact. By unlocking a deeper understanding of driver behavior, we are on a mission to make every journey smarter, safer, and more responsive to the needs of the driver.